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We thank Dr Yanai and Dr Hirowatari for their interest
in our article.
The role of uric acid (UA) in human disease is still
controversial. Most studies have found a significant
association between serum UA levels and cardiovascular
outcomes, particularly in women, but this link was not
always independent of other cardiovascular risk factors.
Moreover, UA seems to be protective against some
diseases (eg, in the neurological field) for its antioxidant
activity,1 but exerts a pro-oxidant action within the
adipocytes2 and in conditions of local ischemia.3
Taking into account these polymorphic actions of
UA, the discrepancies between the results observed by
Yanai and Hirowatari and our own findings are not
surprising. There are clear differences between their
diabetic population sample and patients who partici-
pated in our study.4 First of all, age was in a wider range
than in our population, which comprised only elderly
patients. Second, body mass index was normal or only
slightly increased, as one would expect in a Japanese
population, while we mostly recruited obese patients.
This is a meaningful point, because a positive associa-
tion between body mass and serum UA levels has been
widely described, not only with fatty mass but also with
lean mass.5
It is interesting that, even in such a different setting,
Yanai and Hirowatari confirmed, in the context of the
diabetic disease, our observation of a sex-specific
pattern of association between serum UA and clinical/
metabolic parameters. However, in a subanalysis of the
patients with type 2 diabetes included in our study, we
did not find any favorable association between UA and
other features of cardiovascular risk, as Yanai and
Hirowatari did in diabetic men. In fact, in our 23
diabetic male participants, serum UA was inversely
correlated with high-density lipoprotein cholesterol
(r=0.460, P<.03) and directly correlated with serum
triglyceride (r=0.433, P<.04) and triglyceride/high-den-
sity lipoprotein cholesterol ratio (r=0.485, P<.02). Even
the 86 diabetic women exhibited a different picture
from their Japanese counterparts: UA was positively
correlated with body mass index (r=0.290) and waist
circumference (r=0.338, P<.003 for both tests). More-
over, an inverse correlation was present between UA
and estimated glomerular filtration rate in women
(r=0.303, P<.007).
Hence, in our subsample of diabetic patients, serum
UA was associated with other features of the metabolic
syndrome and with signs of target organ damage in a
similar way to that observed in the whole population of
elderly, mostly obese, Neapolitan patients. However, on
the basis of the different actions of UA described in the
literature, it is theoretically conceivable that in select
cases, as in the lean, male diabetics observed by Yanai
and Hirowatari, UA might exert a protective role.
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